Provided by Tiger Trade Technology Pte. Ltd.

Recursion Pharmaceuticals, Inc.

3.98
0.0000
Post-market: 3.980.00000.00%19:59 EST
Volume:14.18M
Turnover:55.94M
Market Cap:2.07B
PE:-2.23
High:4.00
Open:3.95
Low:3.85
Close:3.98
52wk High:12.36
52wk Low:3.54
Shares:519.84M
Float Shares:415.00M
Volume Ratio:0.49
T/O Rate:3.42%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.7839
EPS(LYR):-1.6909
ROE:-91.06%
ROA:-42.04%
PB:1.98
PE(LYR):-2.35

Loading ...

Feb 04, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Feb 03, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jan 20, 2026

Proposed Sale Of Securities

Form 144 | Recursion Pharmaceuticals Director Christopher Gibson proposes to sell 40,000 shares, with a total value of approximately $178,800
Jan 12, 2026

Major Issues Report

Form 8-K - Current report
Jan 06, 2026

Proposed Sale Of Securities

Form 144 | RECURSION PHARMACEUTICALS' Director B. Borgeson proposes to sell 220,000 shares, with a total value of approximately $959.2K.
Jan 05, 2026

Proposed Sale Of Securities

Form 144 | Recursion Pharmaceuticals' Director Gibson Christopher proposes to sell 40,000 Shares, with a total value of approximately $170,000.
Dec 29, 2025

Proposed Sale Of Securities

Form 144 | Recursion Pharmaceuticals Officer Taylor Ben R proposes to sell 21,383 shares, with a total value of approximately $89K.
Dec 22, 2025

Proposed Sale Of Securities

Form 144 | Recursion Pharmaceuticals' Officer Najat Khan proposes to sell 124,403 Shares, with a total value of approximately $548,587.96
Dec 19, 2025

Proposed Sale Of Securities

Form 144 | Recursion Pharmaceuticals's Officer Christopher Gibson proposes to sell 40,000 shares, with a total value of approximately $180,000.
Dec 08, 2025

Major Issues Report

Form 8-K - Current report
Dec 04, 2025

Proposed Sale Of Securities

Form 144 | Recursion Pharmaceuticals' Officer Christopher Gibson proposes to sell 40,000 shares, with a total value of approximately $185,200.
Dec 02, 2025

Proposed Sale Of Securities

Form 144 | RECURSION PHARMACEUTICALS Director Blake Borgeson proposes to sell 220,000 shares, with a total value of approximately $961,400
Nov 26, 2025

Major Issues Report

Form 8-K - Current report
Nov 19, 2025

Proposed Sale Of Securities

Form 144 | RECURSION PHARMACEUTICALS' Director and Officer Gibson proposes to sell 40000 shares, with a total value of approximately $166,400.
Nov 05, 2025

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Nov 05, 2025

Major Issues Report

Form 8-K - Current report
Nov 04, 2025

Proposed Sale Of Securities

Form 144 | Recursion Pharmaceuticals Officer Christopher Gibson proposes to sell 40,000 Shares, with a total value of approximately $208,400.
Oct 29, 2025

Major Issues Report

Form 8-K - Current report
Oct 23, 2025

Proposed Sale Of Securities

Form 144 | Recursion Pharmaceuticals' Officer Gibson proposes to sell 100,000 shares, with a total value of approximately $570,000.
Oct 10, 2025

Proposed Sale Of Securities

Form 144 | Recursion Pharmaceuticals' Officer Christopher Gibson proposes to sell 100,000 Shares, with a total value of approximately $604,000.